YMRC
MIRM icon

Yorktown Management & Research Company’s Mirum Pharmaceuticals MIRM Stock Holding History

Yorktown Management & Research Company’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$656K Buy
5,600
+3,050
+120% +$306K 0.4% 81
2026
Q1 		$236K Buy
+2,550
New +$240K 0.2% 197

Other funds holding MIRM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.58B AUM 81.2% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return

Yorktown Management & Research Company's MIRM Position: Q2 2026 in Review

Yorktown Management & Research Company increased its Mirum Pharmaceuticals (MIRM) stake by 120% in Q2 2026, buying an estimated $306K and bringing the position to 5,600 shares worth $656K. The position accounts for 0.4% of the portfolio, ranked #81.

Yorktown Management & Research Company first reported a position in MIRM in Q1 2026 and has held it in 2 quarters since. 123 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Yorktown Management & Research Company held 5,600 shares of Mirum Pharmaceuticals worth $656K as of Q2 2026.
  • Yorktown Management & Research Company bought 3,050 Mirum Pharmaceuticals shares in Q2 2026, an estimated $306K.
  • Mirum Pharmaceuticals made up 0.4% of Yorktown Management & Research Company's portfolio in Q2 2026, its #81 holding.
  • Yorktown Management & Research Company first reported a position in Mirum Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 123 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Yorktown Management & Research Company's 13F filing for Q2 2026, filed 23 Jul 2026.